Exhibit 4.2 THIS WARRANT AND THE SECURITIES PURCHASABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR UNDER THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION, AND MAY NOT BE OFFERED, SOLD, OR TRANSFERRED IN...Warrant Agreement • July 3rd, 2000 • Genaissance Pharmaceuticals Inc • Services-commercial physical & biological research • Connecticut
Contract Type FiledJuly 3rd, 2000 Company Industry Jurisdiction
LOAN AGREEMENTLoan Agreement • July 3rd, 2000 • Genaissance Pharmaceuticals Inc • Services-commercial physical & biological research • Connecticut
Contract Type FiledJuly 3rd, 2000 Company Industry Jurisdiction
NEWCOURT FINANCIAL USA INC. Newcourt Financial USA Inc. MASTER LEASE AGREEMENT 301 Lee Farm Corporate Park 83 Wooster Heights Road Danbury, CT 06810 LESSEE: ________________________ MASTER LEASE AGREEMENT NO. ________________ ADDRESS:...Master Lease Agreement • July 3rd, 2000 • Genaissance Pharmaceuticals Inc • Services-commercial physical & biological research
Contract Type FiledJuly 3rd, 2000 Company Industry
CONFIDENTIALStrategic Alliance Agreement • July 3rd, 2000 • Genaissance Pharmaceuticals Inc • Services-commercial physical & biological research • Delaware
Contract Type FiledJuly 3rd, 2000 Company Industry Jurisdiction
FINOVA Technology Finance, Inc. 10 Waterside Drive Farmington, Connecticut 06032-3065 (860) 676-1818 MASTER LEASE No. S6930, Dated October 2, 1998 FINOVA Technology Finance, Inc. ("we", "us" or "FINOVA") agrees to lease to Genaissance Pharmaceuticals,...Master Lease • July 3rd, 2000 • Genaissance Pharmaceuticals Inc • Services-commercial physical & biological research • Arizona
Contract Type FiledJuly 3rd, 2000 Company Industry Jurisdiction
Exhibit 10.16 MASTER EQUIPMENT LEASE AGREEMENTMaster Equipment Lease Agreement • July 3rd, 2000 • Genaissance Pharmaceuticals Inc • Services-commercial physical & biological research
Contract Type FiledJuly 3rd, 2000 Company Industry
Change of plan type - Plan or contract termination - Spin-offs or mergers - A greater than 50% change in the value of the funds or number of members - Adding or removing non-proprietary fundsService and Expense Agreement • July 3rd, 2000 • Genaissance Pharmaceuticals Inc • Services-commercial physical & biological research
Contract Type FiledJuly 3rd, 2000 Company Industry
Exhibit 10.24 June 2, 2000 Mr. Kevin Rakin Executive Vice President Genaissance Pharmaceuticals, Inc. Five Science Park New Haven, CT 06511 Re: Leasehold Improvement Loan Dear Mr. Rakin: Connecticut Innovations, Incorporated, ("CII") has approved a...Leasehold Improvement Loan • July 3rd, 2000 • Genaissance Pharmaceuticals Inc • Services-commercial physical & biological research
Contract Type FiledJuly 3rd, 2000 Company Industry